Cargando…

Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.

Vincristine pharmacokinetic, tumour uptake and therapeutic characteristics were investigated here in order to elucidate the processes underlying the enhanced efficacy observed for vincristine entrapped in small (120 nm) distearoylphosphatidylcholine/cholesterol liposomes. Plasma vincristine levels a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayer, L. D., Masin, D., Nayar, R., Boman, N. L., Bally, M. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033637/ https://www.ncbi.nlm.nih.gov/pubmed/7880728

Ejemplares similares

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
por: Webb, M. S., et al.
Publicado: (1995)

Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Raj, Trisha A Soosay, et al.
Publicado: (2013)

Development and characteristics of novel sonosensitive liposomes for vincristine bitartrate
por: Lin, Wen, et al.
Publicado: (2019)

Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice.
por: Chang, C. W., et al.
Publicado: (1997)

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx(®)) or vincristine
por: Verreault, Maite, et al.
Publicado: (2011)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013)

Development of a stable single-vial liposomal formulation for vincristine
por: Mao, Wenxue, et al.
Publicado: (2019)

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
por: Mathé, G., et al.
Publicado: (1969)

Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly
por: Ma, Siyu, et al.
Publicado: (2017)

Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
por: Yang, Fen, et al.
Publicado: (2018)

Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats.
por: Jori, G., et al.
Publicado: (1983)

The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang, Jing, et al.
Publicado: (2016)

Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”
por: Wang, Chenyu, et al.
Publicado: (2022)

Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
por: Gilabert-Oriol, Roger, et al.
Publicado: (2018)

Effects of ethylene glycol monomethyl (EGME) and monoethyl (EGEE) ethers on the immunocompetence of allogeneic and syngeneic mice bearing L1210 mouse leukemia.
por: Houchens, D P, et al.
Publicado: (1984)

Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.
por: Grdina, D. J., et al.
Publicado: (1983)

The Content of Dipeptidases and Acid Proteinases in the Ascitic Fluid of Mice with Ascites Tumours
por: Sylvén, B., et al.
Publicado: (1959)

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
por: Zhang, Yue, et al.
Publicado: (2017)

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
por: Sehested, M., et al.
Publicado: (1989)

Development of cyclosporin A mediated immunity in L1210 leukaemia.
por: Slater, L. M., et al.
Publicado: (1991)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Treatment with Uncaria tomentosa Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours
por: Zari, Ali, et al.
Publicado: (2021)

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
por: Davis, Tyler, et al.
Publicado: (2013)

Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes
por: Xu, Yuzhen, et al.
Publicado: (2015)

Sheet Formation by Cells of an Ascites Tumour in vitro
por: Trevan, D. J., et al.
Publicado: (1960)

Characterization of a monoclonal antibody to L1210 leukaemia.
por: Testorelli, C., et al.
Publicado: (1982)

Pathology of the Landschütz Ascites Tumour
por: Stuart, A. E., et al.
Publicado: (1964)

Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
por: Hacker, M., et al.
Publicado: (1980)

Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.
por: Verloes, R., et al.
Publicado: (1978)

Catheptic and Dipeptidase Activities of Ascites Tumour Cells
por: Malmgren, H., et al.
Publicado: (1955)

pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines
por: Alrbyawi, Hamad, et al.
Publicado: (2022)

Tumour Cell Invasion from Transplantable Ascites Tumours into Host Tissues
por: Wheatley, D. N., et al.
Publicado: (1964)

Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium
por: Blaheta, R A, et al.
Publicado: (2007)

Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.
por: Wolf, A., et al.
Publicado: (1975)

The Role of Hyperthermia in Potentiation of Anti-Angiogenic Effect of Cisplatin and Resveratrol in Mice Bearing Solid Form of Ehrlich Ascites Tumour
por: Kučan, Darko, et al.
Publicado: (2023)

1210. Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin, et al.
Publicado: (2021)

Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
por: Dessì, S., et al.
Publicado: (1995)

Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice
por: Boehmerle, Wolfgang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gu7c5at08ctp4401as090h6qsf